Shareholder Wang Haibo of Fudan Zhangjiang (01349.HK) plans to reduce his holdings of A shares by no more than 100,000 shares.

ChiNext Financial News App, Fudan Zhangjiang (01349.HK) announced that as of the disclosure date of this announcement, Mr. Wang Haibo, a shareholder of Shanghai Fudan Zhangjiang Biopharmaceutical Co., Ltd. (referred to as the "Company" or "Fudan Zhangjiang"), holds 51.8286 million shares of the Company, accounting for 5.00% of the total share capital of the Company. The shares held by Mr. Wang Haibo are obtained from the shares acquired before the initial public offering of the company, and the shares have been fully released from restrictions and listed for trading since June 19, 2023.